Organoids merging into a human brain

Our September issue

Ethics of human brain organoids, resource competition in synthetic biology, engineered polysaccharides for immunotherapy, photodynamics, cell engineering and more

Announcements

  • NRBioeng logo

    Interested in meeting our editors in a virtual lab or site visit? Click the link above to find out more.

  • Slice of brain with circuits

    Join our free webinar discussing the state of clinical trials of implantable brain-computer interfaces, with field leader Jose Contreras-Vidal and Mariska Vansteensel, an expert in conducting clinical trials of implanted brain machine interfaces.

  • Person with wireless implants walking up stairs

    Neurotechnologies, such as brain-machine interfaces, have the potential to restore functions in individuals with neurological disorders, but face challenges in development, ethics and implementation. In this Collection, we present articles discussing the application and translation of neurotechnologies.

  • Engineering visual

    Nature Reviews Bioengineering is launching a competition asking students and Postdocs around the globe to theoretically tackle some of the most pressing bioengineering challenges. Three challenges are awaiting innovative and creative solutions – from the idea to the sketch of a prototype – take part now!

Advertisement

  • An article in Communications Engineering presents a robotic optical coherence tomography system that offers robust, flexible and automatic scanning of the surface of a full kidney for quality assessment prior to transplantation.

    • Sadra Bakhshandeh
    Research Highlight
  • The FDA Modernization Act 2.0 allows bioengineered models in drug testing, including benchtop testing and computational models. These alternatives to animal testing may particularly advance drug discovery in reproductive and pregnancy research.

    • Samantha G. Zambuto
    • Adrienne K. Scott
    • Michelle L. Oyen
    Comment
  • The establishment of a global bioeconomy will be driven by advances in synthetic biology, bioengineering tools and artificial intelligence. However, achieving a net-zero bioeconomy requires overcoming technological, regulatory and societal challenges to disrupt the current fossil-fuel-based model and place nature at the centre of decision-making.

    • Tara Shirvani
    Comment
  • Optoacoustic (photoacoustic) imaging has seen considerable growth in technological advances and clinical application over the past decade. This piece critically discusses whether optoacoustic imaging can become a mainstream clinical modality.

    • Vasilis Ntziachristos
    Comment
  • Photochemistry enables biomaterials to be made and modified with high spatiotemporal and dose-dependent precision. In this Review, the authors investigate the recent and parallel developments in light-based chemistries and manufacturing technologies and discuss their combined applications in probing and directing 4D cell fate.

    • Irina Kopyeva
    • Ryan P. Brady
    • Cole A. DeForest
    Review Article
  • Photoacoustic imaging (PAI) has generated much interest in preclinical studies and shows great potential for clinical translation. Here, the authors discuss the fundamentals of PAI technology, key findings from pilot and clinical patient studies, challenges to the clinical translation of PAI, and the need for standardization for PAI to be adopted into healthcare systems.

    • Jeongwoo Park
    • Seongwook Choi
    • Chulhong Kim
    Review Article
  • The transplantation of encapsulated islets may provide a cure for type 1 diabetes. This Review outlines how islet-encapsulation devices and materials can be designed to protect islets from the host immune system, allow sufficient nutrient and oxygen supply, and enable revascularization as well as insulin release.

    • Sophie S. Liu
    • Surim Shim
    • Kisuk Yang
    Review Article
  • Virus nanotechnology can be exploited for intratumoural immunotherapy. This Review discusses the clinical and preclinical landscape of viruses and virus-like particles as tools and carrier vehicles for intratumoural immunotherapy.

    • Anthony O. Omole
    • Zhongchao Zhao
    • Nicole F. Steinmetz
    Review Article
  • Information on clinical trial progress and outcomes of implanted brain–computer interfaces (iBCIs) remains limited. This Review provides a comprehensive survey of all identified clinical trials of iBCIs for communication, motor control or restoration of tactile perception conducted from the first chronic implantation in 1998 to December 2023.

    • K. Michelle Patrick-Krueger
    • Ian Burkhart
    • Jose L. Contreras-Vidal
    Review Article